Company

SinoMab BioScience

As of the edition of 20 October 2026, SinoMab BioScience runs 2 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active2
Total2

Where its trials are

  • Immune system: 7 trials led
  • Skin and connective tissue: 6 trials led
  • Bones, joints and muscles: 3 trials led